Immunomedics, Inc. (NASDAQ:IMMU) rose to $3.58 per share in the last trading day compared to a prior close of $3.55. The management team hold ...
News
- Intraday Active Biotech Stocks News: Immunomedics, Inc. (NASDAQ:IMMU), Radius Health, Inc ...
- Maryland's Harris meets with Trump — perhaps about NIH post
"Dr. Collins is the right person, at the right time, to continue to lead the world's premier biomedical research agency," four lawmakers, including Sen.
- 2 Biotech Stocks News And Price Trends: Radius Health (NASDAQ:RDUS), CytRx (NASDAQ:CYTR)
... in patients with estrogen receptor positive (ER+) breast cancer, which were presented this morning at the San Antonio Breast Cancer Symposium ...
- KB Home Announces the Grand Opening of Hidden Canyons at Texas Research Park in Far West ...
It is especially convenient for biomedical researchers and others working in one of the TRP's many facilities, as well as employees of the nearby ...
- Biden outlines steps to pursue post-Obama 'cancer moonshot'
... improve access to care and push pharmaceutical companies, insurance providers and biotech companies to ensure patients can afford treatments.